http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1510664-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4dae7331034b6b26116b7c2f7acb115 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0489 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
filingDate | 1975-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1978-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | GB-1510664-A |
titleOfInvention | Bone-seeking technetium-99m imidodiphosphonate complex |
abstract | 1510664 Radioactive substances RESEARCH CORP 13 Oct 1975 [30 May 1975] 41817/75 Heading G6R A gamma ray-emitting skeletal imaging agent comprises a solution of complex of technetium 99m, tin, and imidodiphosphonic acid or a salt thereof. The complex may be prepared by reducing a pertechnetate containing Tc99m with stannous ion in an aqueous medium in the presence of imidodiphosphonic acid or a salt thereof. Freeze-dried stannous imidodiphosphonate complex (see Specification 1,510,665) may be mixed with the pertechnetate solution just prior to use. The imaging agent is injected intravenously and becomes localized in bones, particularly in diseased areas. |
priorityDate | 1975-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.